When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CVAC - Is CureVac a Bargain Bet on mRNA Vaccine Technology?
CureVac N.V.
CureVac (NASDAQ: CVAC) is working on mRNA coronavirus vaccine candidates. If it's successful, mRNA vaccine giants Moderna and Pfizer will face competition. In this Motley Fool Live video recorded on June 22 , healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss whether investors should buy CureVac shares as a way to invest in this game-changing technology.